REACTIVATED - New - Common Professional Services - SOAR 210569-2-Operations Coordinator - HHS OMAS (PCA-NIAID-04026)
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The National Institutes of Health, under HHS OMAS (PCA-NIAID-04026), plans to procure operations coordinator services through a new requirement under SOAR 210569-2, with the estimated solicitation release and award both set for 2026-07-01. The task order supports LMVR-NIAID's clinical, administrative, and research functions, including biosafety and security for eight human clinical trials conducted by three clinical investigators, safe handling of time-sensitive human biospecimens, and continuous animal colony maintenance and oversight, all under Good Clinical Practice standards, 45 CFR part 46, and Institutional Animal Care and Use Committee regulations. The 2026-11-14 posting states that services have already lapsed and that the program is not manageable without this support.
The estimated award value range is $250,000 to $700,000 under NAICS 541990 (All Other Professional, Scientific, and Technical Services), with no set-aside used. Kishan Patel, Contracting Officer at the National Institutes of Health (kishan.patel@nih.gov, +12406695157), and Desta Mills at the National Institute of Allergy and Infectious Diseases (millsde@niaid.nih.gov) are the listed points of contact.
Forecast text
~SERVICES HAVE ALREADY LAPSED~
The services administered under this task order are essential to the operational continuity of LMVR-NIAID's clinical, administrative and research functions directly supporting human safety, biosafety, and security within the laboratory for eight human clinical trials conducted by three clinical investigators. Oversight includes safe handling and processing of time-sensitive human biospecimens from clinical studies and animal protocols, ensuring biosafety, ethical conduct, and good stewardship for humans and animals. Without continued support, the active oversight for human welfare as it relates to clinical patient biospecimen samples and data will be jeopardized. Patient data of clinical trial participants are handled with strict confidence as a matter of adherence to the Good Clinical Practice standards for Human Subjects Research (as dictated by HHS Regulations for the Protection of Human Subjects (see 45 CFR part 46). Additionally, strict adherence to approved animal protocols is imperative to ethical conduct as outlined by the Institutional Animal Care and Use Committee regulations. Given the burden of the amount of clinical patient data and biospecimen samples yielded from 8 clinical trials conducted by NIH investigators, and the needed continuous animal colony maintenance and oversight on ethical handling for experimental procedures, this support is essential and this program is not manageable without it.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast